Belite Bio, Inc

NASDAQ:BLTE

Biotechnology

Healthcare
$151.02 +0.31%

+$0.46 today

Market cap
$6.08B
Beta
-1.24
P/E (TTM)
-65.9
EPS (TTM)
-$2.26
52W Low $56.10High $200.00

Volume 0.14M

Average 0.17M

Price history

Belite Bio, Inc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+38.32%

Period high

$193.61

Period low

$109.18

Latest

$151.02

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
6-KNov 12, 2026Nov 12, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 30, 2026Oct 30, 2026
6-KOct 19, 2026Oct 19, 2026
4Oct 5, 2026Oct 5, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 9, 2026Sep 9, 2026
6-KSep 8, 2026Sep 8, 2026
4Aug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026
6-KAug 13, 2026Aug 12, 2026
144Aug 12, 2026Aug 12, 2026
144Aug 12, 2026Aug 12, 2026
6-KAug 11, 2026Aug 11, 2026

Competitors

Who does Belite Bio, Inc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BLTE's filings, answered from its disclosures.

What is the latest BLTE filing?

The latest filing shown is 6-K dated Nov 12, 2026.

How many recent filings does BLTE have?

Intrinsic Alpha currently shows 20 recent filings for BLTE.